RecruitingNCT07299565

Analysis of Pharmacological Aspects Regarding Infection Free Survival After Surgical Treatment of a Periprosthetic Knee Infection: a Microdialysis Study

Analysis of Immunological and Pharmacological Aspects Regarding Infection Free Survival After Surgical Treatment of a Periprosthetic Knee Infection During Hospitalization: a Microdialysis Study


Sponsor

University Hospital, Bonn

Enrollment

30 participants

Start Date

Nov 15, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to use the technique of microdialysis to analyse the intraarticular space of the knee joint after removal of a periprosthetic joint infection affected endoprosthesis and implantation of an antibiotic-containing cement spacer over the entire period of the first hospitalization (usually 14 days) to closely monitor pharmacological and immunological aspects. In detail, antibiotic concentrations in the joint cavity and systemic circulation will be assessed according to reinfection rates, infection-free survival and fucntional outcome over a 12-month folluw-up period.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • clinical indication for two-stage revision of knee PJI
  • approval for surgery by the orthopedic and anesthesiologic department
  • being over 18 years of age
  • written, informed consent after detailed patient information about the study protocol and possible study dependent risks

Exclusion Criteria1

  • known allergies to antibiotics gentamicin and vancomycin used within the spacer

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University Hospital Bonn

Bonn, North Rhine-Westphalia, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07299565